✦ LIBER ✦

Deletion of chromosomal region 6q14-16 in prostate cancer

✍ Scribed by Paul C.M.S. Verhagen; Karin G.L. Hermans; Mariel O. Brok; Wytzke M. van Weerden; Marcel G.J. Tilanus; Roel A. de Weger; Tom A. Boon; Jan Trapman

Publisher: John Wiley and Sons
Year: 2002
Tongue: French
Weight: 672 KB
Volume: 102
Category: Article
ISSN: 0020-7136
DOI: 10.1002/ijc.10677

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

A detailed analysis of chromosome 6 in DNAs from prostate cancers was performed, to define a region for subsequent search for cancer genes. DNA from 4 prostate cancer cell lines and 11 xenografts was used for CGH and whole‐chromosome allelotyping with polymorphic microsatellite markers. Loss of proximal 6q was studied in more detail by high‐density allelotyping of xenografts, cell lines and 19 prostate tumour specimens from TURP. Seven of 15 xenografts and cell lines showed deletion of proximal 6q by CGH. Gain of 6q was found in 2 samples. Six samples showed 6p gain, and 1 had 6p loss. Allelotyping results were consistent with CGH data in 11 of 15 DNAs. In LNCaP and DU145 cells, CGH showed 6p loss and 6q loss, respectively, but 2 allelic bands were detected for many polymorphic markers on these chromosome arms. These apparent discrepancies might be explained by aneuploidy. In cell line TSU, allelotyping demonstrated chromosome 6 deletion, which was not clearly detected by CGH, indicating loss of 1 copy of chromosome 6 followed by gain of the retained copy during progressive tumour growth. Loss of heterozygosity was detected in 9 of 19 TURP specimens. Combining all data, we found a common minimal region of loss at 6q14‐16 with a length of 8.6 Mbp flanked by markers D6S1609 and D6S417. One hundred and twenty‐three STSs, ESTs, genes and candidate genes mapping in this interval were used to screen xenografts and cell lines for HDs, but none was detected. In summary, chromosome region 6q14‐16 was deleted in approximately 50% of the prostate cancer specimens analysed. The high percentage of loss underscores the importance of genes within this region in prostate cancer growth. © 2002 Wiley‐Liss, Inc.

📜 SIMILAR VOLUMES

Defining the region(s) of deletion at 6q

Defining the region(s) of deletion at 6q16–q22 in human prostate cancer

✍ Eija-Riitta Hyytinen; Rega Saadut; Ceshi Chen; Lindsay Paull; Pasi A. Koivisto; 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 200 KB 👁 1 views

## Abstract Deletion of the long arm of chromosome 6 (6q) frequently occurs in many neoplasms, including carcinomas of the prostate and breast and melanoma, suggesting the location of a tumor‐suppressor gene or genes at 6q. At present, however, the region of deletion has not been well defined, and

Distinct deleted regions on chromosome s

Distinct deleted regions on chromosome segment 16q23–24 associated with metastases in prostate cancer

✍ Chunde Li; Geert Berx; Catharina Larsson; Gert Auer; Ulla Aspenblad; Yi Pan; Bir 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 389 KB 👁 1 views

Cadherins (CDH) are cell adhesion molecules and their dysfunctions have been implicated in the development of cancer metastases. Several cadherin genes are tandemly located on 16q, which is frequently deleted in prostate cancer. We therefore used 22 markers on 16q to localize important deleted regio

Three distinct commonly deleted regions

Three distinct commonly deleted regions of chromosome arm 16q in human primary and metastatic prostate cancers

✍ Hiroyoshi Suzuki; Akira Komiya; Mitsuru Emi; Hiroaki Kuramochi; Taizo Shiraishi; 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 752 KB

Human prostate cancers frequently show loss of heterozygosity (LOH) at loci on the long arm of chromosome I 6 (I 6q). In this study, we analyzed prostate cancer specimens from 48 patients (Stage B, 20 cases; Stage C, I0 cases; cancer death, I 8 cases) for allelic loss on I6q, using either restrictio

Identification of three commonly deleted

Identification of three commonly deleted regions on chromosome arm 6q in human pancreatic cancer

✍ Tadayoshi Abe; Naohiko Makino; Toru Furukawa; Hong Ouyang; Mitsuhiro Kimura; Tos 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 102 KB 👁 2 views

Pancreatic cancer has one of the poorest prognoses among malignant diseases. To understand its molecular mechanisms, we studied allelic losses on the long arm of chromosome 6. Using 55 paired DNAs of tumors and their corresponding normal tissues and 30 microsatellite markers that spanned the entire

Genetic alterations in localized prostat

Genetic alterations in localized prostate cancer: Identification of a common region of deletion on chromosome arm 18q

✍ Alain Latil; Jean-Christophe Baron; Olivier Cussenot; Georges Fournier; Thierry 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 964 KB

Accumulation of mutations in oncogenes and tumor suppressor genes transforms a normal cell into a malignant cell by allowing it to escape from normal control of growth. In prostate tumorigenesis, the current model envisages specific mutations of the TP53 tumor suppressor gene and loss of loci, detec

Allelic loss on chromosome 6Q in primary

Allelic loss on chromosome 6Q in primary prostate cancer

✍ Vasantha Srikantan; Isabell A. Sesterhenn; Leland Davis; Gerald R. Hankins; Fran 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 183 KB 👁 2 views

Molecular genetic analyses of human prostate cancer (CaP) has revealed frequent loss of specific chromosome regions suggesting the presence of putative tumor suppressor gene(s) (TSG) on these chromosome loci whose inactivation may play a role in prostate tumorigenesis. To understand the role of 6q a